Monday, August 15, 2022
  • Privacy Policy
  • Copyright
TV USA | Live
Weather ☀
Exchange Rates $
  • Politics
  • International
  • Society
  • Sports
  • Blog
  • Contact
No Result
View All Result
  • Politics
  • International
  • Society
  • Sports
  • Blog
  • Contact
No Result
View All Result
TV USA | Live
No Result
View All Result
Home Society

Vast under-treatment of diabetes seen in global study

TV USA | Live by TV USA | Live
May 21, 2021
in Society
0
'We're playing Moneyball with building assets'

Nearly half a billion people on the planet have diabetes, but most of them aren’t getting the kind of care that could make their lives healthier, longer and more productive, according to a new global study of data from people with the condition.

Many don’t even know they have the condition.

Only 1 in 10 people with diabetes in the 55 low- and middle-income countries studied receive the type of comprehensive care that’s been proven to reduce diabetes-related problems, according to the new findings published in Lancet Healthy Longevity.

That comprehensive package of care – low-cost medicines to reduce blood sugar, blood pressure and cholesterol levels; and counseling on diet, exercise and weight – can help lower the health risks of under-treated diabetes. Those risks include future heart attacks, strokes, nerve damage, blindness, amputations and other disabling or fatal conditions.

The new study, led by physicians at the University of Michigan and Brigham and Women’s Hospital with a global team of partners, draws on data from standardized household studies, to allow for apples-to-apples comparisons between countries and regions.

The authors analyzed data from surveys, examinations and tests of more than 680,000 people between the ages of 25 and 64 worldwide conducted in recent years. More than 37,000 of them had diabetes; more than half of them hadn’t been formally diagnosed yet, but had a key biomarker of elevated blood sugar.

The researchers have provided their findings to the World Health Organization, which is developing efforts to scale up delivery of evidence-based diabetes care globally as part of an initiative known as the Global Diabetes Compact. The forms of diabetes-related care used in the study are all included in the 2020 WHO Package of Essential Noncommunicable Disease Interventions.

“Diabetes continues to explode everywhere, in every country, and 80% of people with it live in these low- and middle-income countries,” says David Flood, M.D., M.Sc., lead author and a National Clinician Scholar at the U-M Institute for Healthcare Policy and Innovation. “It confers a high risk of complications such as including heart attacks, blindness, and strokes. We can prevent these complications with comprehensive diabetes treatment, and we need to make sure people around the world can access treatment.”

Flood worked with senior author Jennifer Manne-Goehler, M.D., Sc.D., of Brigham and Women’s Hospital and the Medical Practice Evaluation Center at Massachusetts General Hospital, to lead the analysis of detailed global data.

Key findings

In addition to the main finding that 90% of the people with diabetes studied weren’t getting access to all six components of effective diabetes care, the study also finds major gaps in specific care.

For instance, while about half of all people with diabetes were taking a drug to lower their blood sugar, and 41% were taking a drug to lower their blood pressure, only 6.3% were receiving cholesterol-lowering medications.

These findings show the need to scale-up proven treatment not only to lower glucose but also to address cardiovascular disease risk factors, such as hypertension and high cholesterol, in people with diabetes.

Less than a third had access to counseling on diet and exercise, which can help guide people with diabetes to adopt habits that can control their health risks further.

Even when the authors focused on the people who had already received a formal diagnosis of diabetes, they found that 85% were taking a medicine to lower blood sugar, 57% were taking a blood pressure medication, but only 9% were taking something to control their cholesterol. Nearly 74% had received diet-related counseling, and just under 66% had received exercise and weight counseling.

Taken together, less than one in five people with previously diagnosed diabetes were getting the full package of evidence-based care.

Relationship to national income and personal characteristics

In general, the study finds that people were less likely to get evidence-based diabetes care the lower the average income of the country and region they lived in. That’s based on a model that the authors created using economic and demographic data about the countries that were included in the study.

The nations in the Oceania region of the Pacific had the highest prevalence of diabetes – both diagnosed and undiagnosed – but the lowest rates of diabetes-related care.

But there were exceptions where low-income countries had higher-than-expected rates of good diabetes care, says Flood, citing the example of Costa Rica. And in general, the Latin America and Caribbean region was second only to Oceania in diabetes prevalence, but had much higher levels of care.

Focusing on what countries with outsize achievements in diabetes care are doing well could provide valuable insights for improving care elsewhere, the authors say. That even includes informing care in high-income countries like the United States, which does not consistently deliver evidence-based care to people with diabetes.

The study also shines a light on the variation between countries and regions in the percentage of cases of diabetes that have been diagnosed. Improve reliable access to diabetes diagnostic technologies is important in leading more people to obtain preventive care and counseling.

Women, people with higher levels of education and higher personal wealth, and people who are older or had high body mass index were more likely to be receiving evidence-based diabetes care. Diabetes in people with “normal” BMI is not uncommon in low- and middle-income countries, suggesting more need to focus on these individuals, the authors say.

The fact that diabetes-related medications are available at very low cost, and that individuals can reduce their risk through lifestyle changes, mean that cost should not be a major barrier, says Flood. In fact, studies have shown the medications to be cost-effective, meaning that the cost of their early and consistent use is outweighed by the savings on other types of care later.

###

In addition to Flood, who is a clinical lecturer in hospital medicine at Michigan Medicine, U-M’s academic medical center, the study team includes two others from U-M: Michele Heisler, M.D., M.P.A., a professor of internal medicine and member of IHPI, and Matthew Dunn, a student at the U-M School of Public Health. The study was funded by the National Clinician Scholars Program at IHPI, and by the National Institute of Diabetes and Digestive and Kidney Diseases, Harvard Catalyst, and the National Center for Advancing Translational Sciences.

TV USA | Live

See author's posts

Tags: CardiologyDeveloping CountriesDiabetesDiet/Body WeightDisease in the Developing WorldEndocrinologyHealth CareHealth Care Systems/ServicesMedicine/HealthMetabolism/Metabolic Diseases
Previous Post

Microsoft pushes into grocery tech market in deal with China’s Hanshow

Next Post

Investing in gold? It’s ‘relatively cheap’ and could surge: Strategist

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Stories

  • Capitol Hill's dangerous kangaroo court

    The desperation of the Jan. 6 House Committee

    0 shares
    Share 0 Tweet 0
  • U.S. sanctions on Russia violate the Constitution

    0 shares
    Share 0 Tweet 0
  • Voting kicks off in a New York City mayor’s race like no other

    0 shares
    Share 0 Tweet 0
  • Unleash the Power of Postbiotics in Pets

    0 shares
    Share 0 Tweet 0
  • Tensions Rise Over Future of Abortion Rights in US

    0 shares
    Share 0 Tweet 0

International

Saskatchewan’s Sweet Nutrition quadruples sales since 2019, lands deal with 7-Eleven
International

Saskatchewan’s Sweet Nutrition quadruples sales since 2019, lands deal with 7-Eleven

June 29, 2022
Saskatchewan’s Sweet Nutrition quadruples sales since 2019, lands deal with 7-Eleven
International

Saskatchewan’s Sweet Nutrition quadruples sales since 2019, lands deal with 7-Eleven

June 29, 2022
Saskatoon artist inks locals to raise money for Ukraine
International

Saskatoon artist inks locals to raise money for Ukraine

June 28, 2022
‘I kept it hidden’: Survivor of Kamloops Indian Residential School speaks for 1st time
International

‘I kept it hidden’: Survivor of Kamloops Indian Residential School speaks for 1st time

June 28, 2022
‘A body check’: Kids restrained over 2000 times in one year in Ontario’s child-welfare system
International

‘A body check’: Kids restrained over 2000 times in one year in Ontario’s child-welfare system

June 28, 2022
WATCH: Global National – June 27
International

WATCH: Global National – June 27

June 28, 2022
NOTE FROM JOÃO BAPTISTA BORGES, EMERGENCY PLAN TO COMBAT EPIDEMIC COVID-19: MINEA WANTS AN EPAL THAT MEETS THE POPULATION’S NEEDS
International

NOTE FROM JOÃO BAPTISTA BORGES, EMERGENCY PLAN TO COMBAT EPIDEMIC COVID-19: MINEA WANTS AN EPAL THAT MEETS THE POPULATION’S NEEDS

June 16, 2022

TV USA | Live

 JNews - Premium WordPress news & magazine theme by Jegtheme.

 

 

© 2022 JNews. All rights reserved.

No Result
View All Result
  • Politics
  • International
  • Society
  • Sports
  • Blog
  • Contact

© 2022 JNews - Premium WordPress news & magazine theme by Jegtheme.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT